Does the type of hormone replacement therapy influence the risk of deep vein thrombosis?
The risk of developing DVT may be higher in users of combined estrogen-progestin HRT than in users of estrogen-only HRT.
TTT could be performed during any period of the day, and even in the 2 periods to enhance positivity. Considering the low reproducibility rate of the positive tests, serial TTT to evaluate therapeutic efficacy should be performed during the same period of the day.